Nuclein LLC is a newly established company and its core activity lies in the field of democratized DNA testing (Direct To Consumer DNA testing – DTC DNA testing) and digital personalized medicine/health. Nuclein strives to become the leading force in the field of secure democratized DNA testing in Europe and in the world. The main products and services of Nuclein will be:

 Providing comprehensive non-processed DNA data to the end-user (e.g. full exome or full genome sequencing)

 Complete analysis and easily understandable and intuitive interpretation of already obtained DNA data, in order to determine the risk of developing cancer, determine the risk of developing cardiovascular diseases, determine the response of pharmacotherapy, determine ancestry, traits etc.

 Establish distributive genetic information databases and their subsequent sale. End users will be the sole entity with the ability to control the access to their personal genetic information, and at the same time...
Nuclein LLC is a newly established company and its core activity lies in the field of democratized DNA testing (Direct To Consumer DNA testing – DTC DNA testing) and digital personalized medicine/health. Nuclein strives to become the leading force in the field of secure democratized DNA testing in Europe and in the world. The main products and services of Nuclein will be:

 Providing comprehensive non-processed DNA data to the end-user (e.g. full exome or full genome sequencing)

 Complete analysis and easily understandable and intuitive interpretation of already obtained DNA data, in order to determine the risk of developing cancer, determine the risk of developing cardiovascular diseases, determine the response of pharmacotherapy, determine ancestry, traits etc.

 Establish distributive genetic information databases and their subsequent sale. End users will be the sole entity with the ability to control the access to their personal genetic information, and at the same time have the ability to monetize it by selling it to academic establishments, research institutes, major pharmaceutical companies etc. Nuclein will, in fact, receive a percentage of each transaction.

The Nuclein team consists of the co-founders Goran Kungulovski, PhD (CTO), Ivan Kungulovski, PhD (CEO), and Gligor Dachevski (Advisor).
More information

Employees

Goran Kungulovski
Admin